Race, Ethnicity, and Breast Cancer: Treatment- Virtual Workshop 2
Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago
Educational Partner: The Academy for Continued Healthcare Learning (ACHL)
Medium: Online Presentation
Commercial Support: Supported by educational grants from Astra Zeneca and Daiichi Sankyo.
This activity is intended for oncologists, surgical oncologists, radiologists, oncology nurses, OB-GYNs, internal medicine physicians, NPs, PAs and technologists) and administrative teams (case managers, patient navigators, assistive personnel) at the University of Chicago and Ingalls Memorial managing the care of breast cancer patients.
At the conclusion of this activity, participants will be able to:
- Discuss biological differences in breast cancer across different ethnic/racial groups, including tumor biology and genetic factors;
- Describe disparities that negatively impact time to treatment;
- Outline considerations in the selection of therapy and toxicity management across diverse populations of women with breast cancer.
WANT TO KNOW MORE?
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office via email at Nilsa.Santos@uchospitals.edu.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
Assistant Professor, Breast Medical Oncology
The University of Chicago
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University Of Chicago Pritzker School Of Medicine designates this live activity for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.